(Total Views: 810)
Posted On: 03/22/2021 6:41:52 PM
Post# of 155918
Figuring All This Stuff Out. 200 Each in CD16 and CD17. Up from what 140.
This must be for full approval for LL.
After m/m trial, Nader "discussed" EUA with the FDA and then did not apply.
After s/c, Nader said he was "discussing" EUA with the FDA, and today he said he discussed the EUA with Amarex before applying, and then, he did apply. So we could reasonably say that he could be expecting an approval.
There is not a good drug/treatment for critically ill covid-19 patients to prevent death and the world know LL works. Pressure is on the FDA, it has been discussed, they have our application, the demand is out of the galaxy, the data for under 66 is compelling. Death or Leronlimab.
This must be for full approval for LL.
After m/m trial, Nader "discussed" EUA with the FDA and then did not apply.
After s/c, Nader said he was "discussing" EUA with the FDA, and today he said he discussed the EUA with Amarex before applying, and then, he did apply. So we could reasonably say that he could be expecting an approval.
There is not a good drug/treatment for critically ill covid-19 patients to prevent death and the world know LL works. Pressure is on the FDA, it has been discussed, they have our application, the demand is out of the galaxy, the data for under 66 is compelling. Death or Leronlimab.
(6)
(0)
